Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
53.1M
-
Shares change
-
-51.8K
-
Total reported value, excl. options
-
$4.16B
-
Value change
-
-$1.23M
-
Put/Call ratio
-
0.72
-
Number of buys
-
155
-
Number of sells
-
-127
-
Price
-
$79.08
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2020
321 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q2 2020.
Emergent BioSolutions Inc. - Common Stock (EBS) has 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.1M shares
of 54.5M outstanding shares and own 97.47% of the company stock.
Largest 10 shareholders include Copper Rock Capital Partners, LLC (8.77M shares), BlackRock Inc. (6.87M shares), VANGUARD GROUP INC (4.75M shares), Neuberger Berman Group LLC (2.99M shares), STATE STREET CORP (2.22M shares), EARNEST PARTNERS LLC (1.54M shares), DIMENSIONAL FUND ADVISORS LP (1.25M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (969K shares), SNYDER CAPITAL MANAGEMENT L P (891K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (874K shares).
This table shows the top 292 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.